Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) FCF Margin (2020 - 2025)

Maxcyte (MXCT) has disclosed FCF Margin for 6 consecutive years, with 92.85% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 20141.0% to 92.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 172.63% through Dec 2025, down 8361.0% year-over-year, with the annual reading at 172.63% for FY2025, 9688.0% down from the prior year.
  • FCF Margin for Q4 2025 was 92.85% at Maxcyte, up from 108.3% in the prior quarter.
  • The five-year high for FCF Margin was 92.85% in Q4 2025, with the low at 189.47% in Q1 2024.
  • Average FCF Margin over 5 years is 69.24%, with a median of 94.16% recorded in 2022.
  • The sharpest move saw FCF Margin plummeted -12088bps in 2024, then soared 20141bps in 2025.
  • Over 5 years, FCF Margin stood at 50.8% in 2021, then decreased by -17bps to 42.26% in 2022, then plummeted by -127bps to 11.46% in 2023, then tumbled by -847bps to 108.56% in 2024, then skyrocketed by 186bps to 92.85% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 92.85%, 108.3%, and 109.2% for Q4 2025, Q3 2025, and Q2 2025 respectively.